from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0905/echA6

LFCtreatmentdescriptionclass of inhibitor

0.869

Amikacinug/mL Amikacintranslation

1.740

Cap5-10ug/mL Capreomycintranslation

1.363

Rox10-50 ug/mL Roxithromycintranslation

0.824

SM2-5 ug/mL Streptomycintranslation

1.880

Tet5-10 ug/mL Tetracyclinetranslation

-0.272

Rif0.2-5ug/mL Rifampicintranscription

-0.310

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.874

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.312

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-1.355

CPZ10-50 ug/mL Chlorpromazinerespiration

0.212

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.394

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.095

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.036

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.510

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.019

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.318

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.071

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

2.234

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.778

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.021

KCN5-20 ug/mL Potassium cyaniderespiration

1.365

NaN30.2-2 mM Sodium aziderespiration

1.154

Nigericin50 uM Nigericinrespiration

0.168

TRC10-150 ug/mL Triclosanrespiration

-0.895

TRZ10-25 ug/mL Thioridazinerespiration

-1.065

Valinomycin0.5-10 uM Valinomycinrespiration

-0.294

ZnSO42 mM ZnSO4respiration

0.618

menadione6-10 ug/mL Menadionerespiration

0.129

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.043

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.305

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.108

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

1.263

NRP_1Non-replicating persistence stage 1dosRassociated

-0.509

Amp0.2mg/mL AmpicillincellWall

0.204

Cephalexin20-100 ug/mL CephalexincellWall

0.970

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.446

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.174

EMB10-20 ug/mL EthambutolcellWall

1.495

Eta12-40 ug/mL EthionamidecellWall

1.732

INH0.2-0.4 ug/mL IsoniazidcellWall

0.767

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.986

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.577

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.760

BZA0.12 mg/mL BenzamidearomaticAmides

-0.607

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.501

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.040

H2O24 mM hydrogen peroxideDNAdamaging

0.307

Levo10 ug/mL LevofloxacinDNAdamaging

-0.083

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.721

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.247

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.467

UVUV-irradiationDNAdamaging

-1.368

ARP41-4 ug/mL Antitubercular compound ARP4?

0.111

Antimycin12.5-50 ug/mL Antimycin A?

-0.418

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.844

PA_110-50 ug/mL Antitubercular compound PA-1?

0.801

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.174

PA8240.2-2 ug/mL PA-824?

2.392

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.574

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.392

Verapamil50 uM Verapamil?

-0.170

mercaptoethanol2 mM 2-Mercaptoethanol?

0.078

methoxatin10-20 ug/mL Methoxatin?